Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer

Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-23T15:59:09.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-16T16:00:40.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-09T16:12:36.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The study page now renders as a 403 Forbidden error, showing a minimal HTML page with a 403 message and a Home link instead of the usual study content. As a result, access to the study file and related materials is blocked, altering the page’s main function of presenting trial details.
    Difference
    17%
    Check dated 2026-09-25T18:31:51.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.7.0, replacing the previous v3.6.6, signaling an update in the documented page version. This is an administrative change and does not affect the study details or other content.
    Difference
    0.0%
    Check dated 2026-09-18T18:53:24.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page adds an NIH grant/contract annotation for 2015 and updates the revision tag to v3.6.6. It also removes certain related topics (Ovarian cancer and MedlinePlus Genetics) and the older revision tag (v3.6.5), reflecting a refinement of navigational metadata.
    Difference
    0.1%
    Check dated 2026-08-28T07:52:37.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.